Tocilizumab for Severe Worsening COVID-19 Pneumonia: a Propensity Score AnalysisFélix Ackermann, Anne‐Laure Brun, Charles Cerf et al.|Journal of Clinical Immunology|2020Cited by 53
The ID NOW COVID-19, a high-speed high-performance assayÉric Farfour, C Amiel, Marianne Asso‐Bonnet et al.|European Journal of Clinical Microbiology & Infectious Diseases|2021Cited by 16
Tocilizumab to Prevent Ventilatory Support for Severe Worsening COVID-19 Pneumonia: A Propensity Score AnalysisMathilde Roumier, Félix Ackermann, Romain Paule et al.|SSRN Electronic Journal|2020Cited by 1